ophthalmologic innovations

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Yd Bio Limited

YD Bio Posts 17% Revenue Growth to $596.8M, But Swings to Net Loss on Expansion Costs

$YDES reports strong 17% revenue growth to $596.8M in 2025, but net loss of $8.3M as operating expenses surge during business expansion.
YDESYDESWbusiness combinationM&A strategy